Advertisement
New Zealand markets close in 16 minutes
  • NZX 50

    11,702.18
    -92.63 (-0.79%)
     
  • NZD/USD

    0.6149
    +0.0001 (+0.02%)
     
  • NZD/EUR

    0.5676
    +0.0011 (+0.19%)
     
  • ALL ORDS

    8,021.70
    -48.40 (-0.60%)
     
  • ASX 200

    7,772.90
    -49.40 (-0.63%)
     
  • OIL

    82.93
    -0.23 (-0.28%)
     
  • GOLD

    2,392.60
    -5.10 (-0.21%)
     
  • NASDAQ

    20,391.97
    +205.37 (+1.02%)
     
  • FTSE

    8,203.93
    -37.33 (-0.45%)
     
  • Dow Jones

    39,375.87
    +67.87 (+0.17%)
     
  • DAX

    18,475.45
    +24.95 (+0.14%)
     
  • Hang Seng

    17,561.39
    -238.22 (-1.34%)
     
  • NIKKEI 225

    40,957.61
    +45.24 (+0.11%)
     
  • NZD/JPY

    98.6470
    -0.1440 (-0.15%)
     

Novo, Lilly Tumble After Study Ties Blindness Disorder To Weight-Loss Drugs

Novo, Lilly Tumble After Study Ties Blindness Disorder To Weight-Loss Drugs

Novo Nordisk stock skidded Wednesday after a new study suggests its diabetes and weight-loss drug can lead to a blindness-causing disease.